Evaluation the Safety and Efficacy of Cilostazol in Treatment of Patients With Fatty Liver Disease

Summary

The aim of the current study is to evaluate the safety and efficay of cilostazol in treatment of patients with fatty liver disease. Several previous reports have shown that cilostazol ameliorates lipid imbalances in NAFLD. Cilostazol appeared to exert beneficial effects against NAFLD

Timeline

Start

2021-02-16

Primary completion

2024-10-31

Completion

2024-12-31

Outcome

Outcome not reported

Stopped (Business): “Institutional and funding constrains”

Drugs

Indications